The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Source:http://linkedlifedata.com/resource/pubmed/id/17981067

Download in:

View as

General Info

PMID
17981067